These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 8780524)

  • 21. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
    Sotriffer CA; Krämer O; Klebe G
    Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of aldose reductase inhibition: binding of NADP+/NADPH and alrestatin-like inhibitors.
    Ehrig T; Bohren KM; Prendergast FG; Gabbay KH
    Biochemistry; 1994 Jun; 33(23):7157-65. PubMed ID: 8003482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human placental aldose reductase: role of Cys-298 in substrate and inhibitor binding.
    Bhatnagar A; Liu SQ; Ueno N; Chakrabarti B; Srivastava SK
    Biochim Biophys Acta; 1994 Apr; 1205(2):207-14. PubMed ID: 8155699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose and aldehyde reductases: correlation of molecular modeling and mass spectrometric studies on the binding of inhibitors to the active site.
    El-Kabbani O; Rogniaux H; Barth P; Chung RP; Fletcher EV; Van Dorsselaer A; Podjarny A
    Proteins; 2000 Nov; 41(3):407-14. PubMed ID: 11025551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Kotani T; Nagaki Y; Ishii A; Konishi Y; Yago H; Suehiro S; Okukado N; Okamoto K
    J Med Chem; 1997 Feb; 40(5):684-94. PubMed ID: 9057855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat.
    Wilson DK; Tarle I; Petrash JM; Quiocho FA
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9847-51. PubMed ID: 8234324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
    Steuber H; Heine A; Podjarny A; Klebe G
    J Mol Biol; 2008 Jun; 379(5):991-1016. PubMed ID: 18495158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.
    Verma M; Martin HJ; Haq W; O'Connor TR; Maser E; Balendiran GK
    Eur J Pharmacol; 2008 Apr; 584(2-3):213-21. PubMed ID: 18325492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor.
    El-Kabbani O; Darmanin C; Oka M; Schulze-Briese C; Tomizaki T; Hazemann I; Mitschler A; Podjarny A
    J Med Chem; 2004 Aug; 47(18):4530-7. PubMed ID: 15317464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil.
    Urzhumtsev A; Tête-Favier F; Mitschler A; Barbanton J; Barth P; Urzhumtseva L; Biellmann JF; Podjarny A; Moras D
    Structure; 1997 May; 5(5):601-12. PubMed ID: 9195881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.
    Kato K; Nakayama K; Mizota M; Miwa I; Okuda J
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1540-5. PubMed ID: 1934175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tracing changes in protonation: a prerequisite to factorize thermodynamic data of inhibitor binding to aldose reductase.
    Steuber H; Czodrowski P; Sotriffer CA; Klebe G
    J Mol Biol; 2007 Nov; 373(5):1305-20. PubMed ID: 17905306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
    Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
    J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
    Ramasamy R; Oates PJ; Schaefer S
    Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Method for isolating tight-binding inhibitors of rat lens aldose reductase.
    Sun G; Ma Y; Gao X; König S; Fales HM; Kador PF
    Exp Eye Res; 2004 Dec; 79(6):919-26. PubMed ID: 15642330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability, multiple-dose pharmacokinetics, and biotransformation of the aldose reductase inhibitor zopolrestat in dogs.
    Schneider RP; Davenport CJ; Hoffmaster KA; Inskeep PB
    Drug Metab Dispos; 1998 Nov; 26(11):1160-6. PubMed ID: 9806960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.
    O'Brien MM; Schofield PJ; Edwards MR
    J Neurochem; 1982 Sep; 39(3):810-4. PubMed ID: 6808090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.